Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”

키워드

참고문헌 (11)

1. Yoon EL, "Waiting for the changes after the adoption of steatotic liver disease", Clin Mol Hepatol, 29, pp.844~850 (2023)
2. Rinella ME, "A multisociety Delphi consensus statement on new fatty liver disease nomenclature", J Hepatol (2023)[DOI]
3. Singal AK, "Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver disease", Hepatology, 75, pp.1026~1037 (2022)
4. Chan WMM, "Prevalence of metabolic syndrome in patients with psoriasis : a crosssectional study in Singapore", Singapore Med J, 61, pp.194~199 (2020)
5. Song SJ, "Can we use old NAFLD data under the new MASLD definition?", J Hepatol (2023)[DOI]
6. Sharma D, "NAFLD : genetics and its clinical implications", Clin Res Hepatol Gastroenterol, 46, pp.102003~ (2022)
7. Meijnikman AS, "Microbiome-derived ethanol in nonalcoholic fatty liver disease", Nat Med, 28, pp.2100~2106 (2022)
8. Yuan J, "Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae", Cell Metab, 30, pp.675~688 (2019)
9. Zhang X, "Clinical care pathway to detect advanced liver disease in patients with type 2 diabetes through automated fibrosis score calculation and electronic reminder messages : a randomised controlled trial", Gut (2023)[DOI]
10. George J, "Adding to the confusion in more than just the name", Clin Mol Hepatol, 29, pp.973~976 (2023)
11. Brennan PN, "Beyond a liver-gut focus : the evolution of gastroenterology and hepatology in challenging the obesity and steatotic liver disease paradigm", Gut (2023)[DOI]

관련 논문AI추천